Αρχική World News Breast Cancer Patient Fights To Have Mastectomy During COVID-19 Restrictions And Succeeds

Breast Cancer Patient Fights To Have Mastectomy During COVID-19 Restrictions And Succeeds

Robin Roberson was diagnosed with breast cancer at the beginning of this year. The diagnosis was stressful enough, but then the coronavirus pandemic put a wrench in her treatment plan.Elective surgeries have been cancelled all over the U.S. due to the coronavirus, and this included Roberson’s double mastectomy surgery that was slated for April 4th at a hospital in Oklahoma City.It’s alarming to think that cancer treatment is considered “elective” in some cases, but, unfortunately, that’s the case for many patients.Photo: YouTube/KJRH -TV | Tulsa | Channel 2
Roberson was diagnosed in late January with two different types of breast cancer. She also had a strong family history; she had lost her maternal aunt and her paternal grandmother to breast cancer, and with the disease on both sides of her family, she was worried about delaying treatment.She had already delayed just a little so that she could be there for her son’s wedding in March. Waiting even longer was out of the question.Photo: Instagram/crowdcween
So she did some research — and eventually she found the Cancer Treatment Center of America (CTCA) in Tulsa. They were available and willing to do her double mastectomy.“Working with a center like CTCA, they are focused completely on cancer,” Roberson told KJRH. “So, the covid crisis didn’t really affect them as much.”Photo: YouTube/KJRH -TV | Tulsa | Channel 2Kevin Tulipana is the regional medical officer for CTCA Tulsa, and he reaffirmed that the center is still doing everything possible to be able to treat patients in spite of the COVID-19 pandemic.“There are very few cases that would be truly elective,” Tulipana said. “Cancer doesn’t wait, cancer is not going to wait for COVID, it’s not going to wait for anything else, so we have been doing what we can to get access to patients as much as possible.”
Photo: Instagram/crowdcweenHowever, after finding the center, Roberson hit another snag: her insurance company refused to cover the treatment at CTCA. They actually almost made her go out of state to get the procedure done, but CTCA worked quickly and diligently with them to be able to treat her in Tulsa.“CTCA really spearheaded it along with my husband’s company,” Roberson said. “They are self-insured so that helped because they had to really work together to almost fight the insurance company if you will.”
Roberson got her mastectomy scheduled as soon as possible. Just before she went in for surgery, her friends surprised her outside with special signs and uplifting music.Photo: YouTube/KJRH -TV | Tulsa | Channel 2Now Roberson is sharing her story in the hopes that other patients will be advocates of their own health.“I want to encourage people to explore other options especially if they’re living with a cancer diagnosis and are needing that life-saving surgery. Please look at a facility like CTCA — it is dedicated to that,” Roberson said.Learn more in this video.Proper BCS greatergood_ctg_abovevideoSource

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women Under 40

U.S. breast cancer death rates decreased by about 1% per year between 2013 and 2018. What were the new case rates during that same...

Impressive Responses to PD-1 Blockade in a Large Cohort of Children and Young Adults with Recurrent/Progressive Germline DNA Replication Repair-Deficient Cancers

A large, observational, registry-based study that leveraged systematically collected data gathered both retrospectively and prospectively through the International Replication Repair Deficiency Consortium reveals impressive...

2-Year-Boy Is So Excited To See Himself In Disney’s ‘Encanto’

The importance of representation in media has been a growing topic of concern, and companies have responded by adding more diversity to their characters,...

Man Walks Entire Continent To Spread Awareness About Mental Health & Suicide Prevention

Matthew Fennell is walking over 3,000 miles across Australia for an important cause and one that is near and dear to his heart. Last year,...

Boy Battling Cancer Becomes Honorary Police Officer, Sworn In To 45 Agencies

At just ten years old, Devarjaye “DJ” Daniel has already been through more than most people go through in their entire lives. DJ has been...

Paclitaxel and Carboplatin Not Inferior When Compared with Paclitaxel and Ifosfamide for the Treatment of Patients with Uterine Carcinosarcoma

With regard to overall survival (OS), paclitaxel and carboplatin was not inferior and demonstrated improved progression-free survival (PFS) when compared with paclitaxel and ifosfamide...